Zweig-DiMenna Associates’s Bath & Body Works BBWI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-260,923
Closed -$13.1M 82
2024
Q1
$13.1M Hold
260,923
1.14% 30
2023
Q4
$11.3M Hold
260,923
1.27% 28
2023
Q3
$8.82M Buy
260,923
+17,751
+7% +$645K 1.05% 34
2023
Q2
$9.12M Hold
243,172
1.14% 29
2023
Q1
$8.9M Sell
243,172
-223,342
-48% -$9.36M 1.2% 30
2022
Q4
$19.7M Buy
466,514
+206,200
+79% +$7.69M 2.86% 6
2022
Q3
$8.49M Hold
260,314
1.85% 19
2022
Q2
$7.01M Sell
260,314
-7,612
-3% -$330K 1.33% 27
2022
Q1
$12.8M Sell
267,926
-180,214
-40% -$9.72M 1.71% 19
2021
Q4
$31.3M Sell
448,140
-52,444
-10% -$3.72M 2.53% 5
2021
Q3
$31.6M Sell
500,584
-118,880
-19% -$7.56M 2.19% 5
2021
Q2
$36.1M Buy
619,464
+9,846
+2% +$532K 2.17% 1
2021
Q1
$30.5M Sell
609,618
-82,339
-12% -$3.39M 2.12% 3
2020
Q4
$20.8M Buy
+691,957
New +$20.1M 1.32% 23
2015
Q2
Sell
-3,340
Closed -$255K 253
2015
Q1
$255K Sell
3,340
-4,082
-55% -$295K 0.01% 224
2014
Q4
$519K Buy
+7,422
New +$458K 0.02% 144

Other funds holding BBWI

Zweig-DiMenna Associates's BBWI Position: Q2 2024 in Review

Zweig-DiMenna Associates sold out of Bath & Body Works (BBWI) in Q2 2024, closing a stake of 260,923 shares — an estimated $13.1M sold.

Zweig-DiMenna Associates first reported a position in BBWI in Q4 2014 and held it in 16 quarters. The position peaked at $36.1M in Q2 2021. 521 funds tracked by Wall St. Rank hold BBWI as of Q2 2024.

  • Zweig-DiMenna Associates reported no remaining Bath & Body Works position as of Q2 2024 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 260,923 Bath & Body Works shares in Q2 2024, an estimated $13.1M.
  • Zweig-DiMenna Associates first reported a position in Bath & Body Works in Q4 2014 and held it in 16 quarters.
  • Zweig-DiMenna Associates's Bath & Body Works position peaked at $36.1M in Q2 2021.
  • 521 funds tracked by Wall St. Rank held Bath & Body Works as of Q2 2024.

Based on Zweig-DiMenna Associates's 13F filing for Q2 2024, filed 24 Jul 2024.